Literature DB >> 19204420

Pharmacogenomics and the challenge of health disparities.

S S Lee1.   

Abstract

This paper examines emerging technologies and recent research on population differences in pharmacogenomics and the perspectives of scientists, community advocates, policymakers, and social critics on the use of race as a proxy for genetic variation. The discussion focuses on how recent developments in genomic science impact social understandings of racial difference and the public health goal to eliminate ongoing health disparities among racially identified groups. This paper examines how factors such as governmental policies--requiring the use of racial and ethnic categories in genetic research and increasing interest in identifying untapped racial market niches by the pharmaceutical and biotechnology industries--and weak governmental oversight of race-based therapeutics converge to create an 'infrastructure of racialization' that may alter the vision of personalized medicine that has been so highly anticipated. This paper argues that significant public investment in pharmacogenomics requires careful consideration of the emerging discourse that tethers racial justice to notions of racial biology and discusses the social and ethical implications for the pendulum shift towards a geneticization of race in drug development. Copyright 2009 S. Karger AG, Basel.

Mesh:

Year:  2009        PMID: 19204420     DOI: 10.1159/000189630

Source DB:  PubMed          Journal:  Public Health Genomics        ISSN: 1662-4246            Impact factor:   2.000


  10 in total

1.  Pharmacogenomics and public health.

Authors:  D Veenstra; W Burke
Journal:  Public Health Genomics       Date:  2009-02-10       Impact factor: 2.000

2.  Diversity in the Era of Precision Medicine - From Bench to Bedside Implementation.

Authors:  Abdullah Mamun; Nana Y Nsiah; Meenakshi Srinivasan; Ayyappa Chaturvedula; Riyaz Basha; Deanna Cross; Harlan P Jones; Karabi Nandy; Jamboor K Vishwanatha
Journal:  Ethn Dis       Date:  2019-07-18       Impact factor: 1.847

3.  Advancing genomic research and reducing health disparities: what can nurse scholars do?

Authors:  Cheedy Jaja; Robert Gibson; Shirley Quarles
Journal:  J Nurs Scholarsh       Date:  2013-03-01       Impact factor: 3.176

4.  Human difference in the genomic era: Facilitating a socially responsible dialogue.

Authors:  Sarah Knerr; Edward Ramos; Juleigh Nowinski; Keianna Dixon; Vence L Bonham
Journal:  BMC Med Genomics       Date:  2010-05-26       Impact factor: 3.063

5.  After the revolution? Ethical and social challenges in 'personalized genomic medicine'

Authors:  Eric T Juengst; Richard A Settersten; Jennifer R Fishman; Michelle L McGowan
Journal:  Per Med       Date:  2012-06-01       Impact factor: 2.512

6.  Genomic data-sharing: what will be our legacy?

Authors:  Shawneequa Callier; Rajah Husain; Rachel Simpson
Journal:  Front Genet       Date:  2014-03-05       Impact factor: 4.599

7.  Genetic Risk Factors for Alzheimer's Disease in Racial/Ethnic Minority Populations in the U.S.: A Scoping Review.

Authors:  Lindsey Rubin; Lucy A Ingram; Nicholas V Resciniti; Brianna Ashford-Carroll; Katherine Henrietta Leith; Aubrey Rose; Stephanie Ureña; Quentin McCollum; Daniela B Friedman
Journal:  Front Public Health       Date:  2021-12-24

8.  Pharmacogenomics Implementation and Hurdles to Overcome; In the Context of a Developing Country.

Authors:  Nayyereh Ayati; Monireh Afzali; Mandana Hasanzad; Abbas Kebriaeezadeh; Ali Rajabzadeh; Shekoufeh Nikfar
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

9.  Introduction: public health genomics-anthropological interventions in the quest for molecular medicine.

Authors:  Karen-Sue Taussig; Sahra Elizabeth Gibbon
Journal:  Med Anthropol Q       Date:  2013-11-08

10.  Translating Population Difference: The Use and Re-Use of Genetic Ancestry in Brazilian Cancer Genetics.

Authors:  Sahra Gibbon
Journal:  Med Anthropol       Date:  2015-10-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.